InsidersTradesSigma
Browse the detailed record of transactions filed by Cannell Thomas R, Chief Executive Officer. Director active across 1 company, notably Sesen Bio, Inc.. Aggregated, 1 filings have been logged. Activity tracked since 18 February 2022. The latest transaction was filed on 18 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Thomas R. Cannell is the President and CEO of Sesen Bio, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Thomas brings extensive experience in the biopharmaceutical sector, contributing to innovation and growth at Sesen Bio. His leadership is essential to achieve the company's objectives and ensure its sustainability.